FIELD: medical science.
SUBSTANCE: invention refers to medicine, namely to physiotherapy and cardiology, and may be used for the integrated treatment of resistant arterial hypertension. Method involves a diet therapy, a drug therapy and intravenous laser blood irradiation (ILBI). Drug therapy involves administering preparations for 60 days: perindopril in dose of 10 mg, amlodipine in dose of 10 mg, indapamide in dose of 2.5 mg, spironolactone in dose of 25 mg. ILBI involves gradually increasing exposure time.
EFFECT: method enables higher clinical effectiveness in resistant arterial hypertension and lower blood malonic dialdehyde, interleukin-6, endothelin-1, cortisol, higher nitrogen oxide ensured by the simultaneous drug-induced therapy and the use of ILBI.
1 cl, 4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE LONG-TERM ANTIHYPERTENSIVE EFFICACY OF RENAL DENERVATION IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION | 2021 |
|
RU2767134C1 |
| METHOD FOR SELECTING PATIENTS SUFFERING FROM DRUG-RESISTANT ARTERIAL HYPERTENSION FOR PERFORMING RENAL SYMPATHETIC DENERVATION | 2014 |
|
RU2563449C1 |
| METHOD FOR TREATING FACIAL NERVE NEUROPATHY OF NONTRAUMATIC GENESIS | 1997 |
|
RU2162000C2 |
| METHOD OF VEGETATIVE IMBALANCE CORRECTION FOR MEN WITH OBSTRUCTIVE APNEA-HYPOPNEA SYNDROME COMBINED WITH ARTERIAL HYPERTENSION | 2015 |
|
RU2609051C1 |
| METHOD OF TREATING METABOLIC SYNDROME | 2015 |
|
RU2583944C1 |
| METHOD OF TREATING METABOLIC SYNDROME IN EMOTIOGENIC TYPE OF EATING BEHAVIOUR | 2015 |
|
RU2591811C1 |
| METHOD OF DIFFERENTIATED ADMINISTRATION OF MOXONIDINE IN PATIENTS WITH ARTERIAL HYPERTENSION AT BACKGROUND OF METABOLIC SYNDROME | 2010 |
|
RU2426543C1 |
| METHOD FOR COMPLEX TREATMENT OF METABOLIC SYNDROME | 2015 |
|
RU2616125C1 |
| METHOD OF TREATMENT OF ISOLATED SYSTOLIC ARTERIAL HYPERTENSION OF 1 DEGREE IN PATIENTS IN EARLY PERIOD OF OLD AND SENILE AGE | 2019 |
|
RU2726071C1 |
| METHOD OF INCREASING EFFICIENCY OF SHORT-TERM AND MIDDLE-TERM ANTIHYPERTENSIVE THERAPY AND REDUCTION OF LEFT VENTRUCLE HYPERTROPHY IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-ND PHASE OF 2-ND DEGREE OF RISK 3 | 2011 |
|
RU2463043C1 |
